Information about Pelvicura Kinesitherapie
My details
*
*
*

Pelvicura Kinesitherapie (SRL)

BE 1006.315.216

Oscar Van Rumststraat 10, 9160 Lokeren

Company information

Status
Active

Enterprise number

BE1006.315.216

VAT liability
No
Established
22-02-2024
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Other business support service activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Pelvicura Kinesitherapie

2024
Profit/Loss € 30,499
Equity € 35,499
Gross margin € 42,588

Publications from Pelvicura Kinesitherapie

Date Publication
26-02-2024 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the enterprise number of Pelvicura Kinesitherapie?
The enterprise number of Pelvicura Kinesitherapie is BE 1006.315.216.
Wat is the PEPPOL ID of Pelvicura Kinesitherapie?
The PEPPOL ID of Pelvicura Kinesitherapie is 0208:1006315216. Log in or start a free trial to see the full overview.
When was Pelvicura Kinesitherapie founded?
Pelvicura Kinesitherapie was founded on 22-02-2024.
What is the address of Pelvicura Kinesitherapie?
The current registered office of Pelvicura Kinesitherapie is located at Oscar Van Rumststraat 10, 9160 Lokeren.
When was the last time Pelvicura Kinesitherapie filed their annual financial statements?
The most recent financial statements of Pelvicura Kinesitherapie were filed on 31-07-2025.
How many employees does Pelvicura Kinesitherapie have?
There are currently no employees working at Pelvicura Kinesitherapie or no workforce information is available.
What is the annual turnover of Pelvicura Kinesitherapie?
At the time of its most recent financial statements, Pelvicura Kinesitherapie did not publish any turnover figures. Pelvicura Kinesitherapie reported a gross margin of €42,587.56.

Sources